Ana P F Trombone
Overview
Explore the profile of Ana P F Trombone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soares C, Fachin L, Trombone A, Rosa P, Ghidella C, Belone A
Front Med (Lausanne)
. 2018 Oct;
5:263.
PMID: 30320113
The (aldo-keto reductase family 1 member B10) gene has important functions in carcinogen-induced neoplasia. AKR1B10 is also expressed in type 2 reaction leprosy patients (R2). We measured the expression of...
2.
Soares C, Trombone A, Fachin L, Rosa P, Ghidella C, Ramalho R, et al.
Front Immunol
. 2017 Oct;
8:1035.
PMID: 28970833
Leprosy, a chronic infectious disease caused by , is a major public health problem in poor and developing countries of the Americas, Africa, and Asia. MicroRNAs (miRNAs), which are small...
3.
Belone A, Rosa P, Trombone A, Fachin L, Guidella C, Ura S, et al.
Front Genet
. 2015 Dec;
6:334.
PMID: 26635870
Leprosy, an infectious disease caused by Mycobacterium leprae, affects millions of people worldwide. However, little is known regarding its molecular pathophysiological mechanisms. In this study, a comprehensive assessment of human...
4.
Lorenzi J, Trombone A, Rocha C, Almeida L, Lousada R, Malardo T, et al.
BMC Biotechnol
. 2010 Oct;
10:77.
PMID: 20961459
Background: mRNAs are highly versatile, non-toxic molecules that are easy to produce and store, which can allow transient protein expression in all cell types. The safety aspects of mRNA-based treatments...
5.
Rosada R, de la Torre L, Frantz F, Trombone A, Zarate-Blades C, Fonseca D, et al.
BMC Immunol
. 2008 Jul;
9:38.
PMID: 18647414
Background: The greatest challenges in vaccine development include optimization of DNA vaccines for use in humans, creation of effective single-dose vaccines, development of delivery systems that do not involve live...
6.
Franco L, Wowk P, Silva C, Trombone A, Coelho-Castelo A, Oliver C, et al.
Genet Vaccines Ther
. 2008 Jan;
6:3.
PMID: 18208592
Background: A number of reports have demonstrated that rodents immunized with DNA vaccines can produce antibodies and cellular immune responses presenting a long-lasting protective immunity. These findings have attracted considerable...